Skip to main content
placeholder image

The effect of erlotinib on CYP3A4 activity, as quantified by the erythromycin breath test and oral midazolam kinetics in cancer patients: Preliminary results

Journal Article


Abstract


Publication Date


  • 2005

Citation


  • Calvert, H., Twelves, C., Ranson, M., Anthoney, A., Plummer, R., Fettner, S., . . . Rakhit, A. (2005). The effect of erlotinib on CYP3A4 activity, as quantified by the erythromycin breath test and oral midazolam kinetics in cancer patients: Preliminary results. Journal of Clinical Oncology, 23(16_suppl), 3076. doi:10.1200/jco.2005.23.16_suppl.3076

Web Of Science Accession Number


Start Page


  • 3076

End Page


  • 3076

Volume


  • 23

Issue


  • 16_suppl

Abstract


Publication Date


  • 2005

Citation


  • Calvert, H., Twelves, C., Ranson, M., Anthoney, A., Plummer, R., Fettner, S., . . . Rakhit, A. (2005). The effect of erlotinib on CYP3A4 activity, as quantified by the erythromycin breath test and oral midazolam kinetics in cancer patients: Preliminary results. Journal of Clinical Oncology, 23(16_suppl), 3076. doi:10.1200/jco.2005.23.16_suppl.3076

Web Of Science Accession Number


Start Page


  • 3076

End Page


  • 3076

Volume


  • 23

Issue


  • 16_suppl